Cuba creates four anti-cancer vaccines, media ignores it


That Cuba has already developed four vaccines or inoculations against different types of cancer is without doubt important news for humanity. The World Health Organisation says each year about 8 million people die from this illness.

However, the international mainstream media have almost totally ignored this news.

Last year, Cuba patented the first therapeutic vaccine against advanced lung cancer in the world, called CIMAVAX-EGF. In January, the second one, called Racotumomab, was announced.

Clinical testing in 86 countries shows that these vaccines, although they don’t cure the illness, do managed to reduce tumours and allow for a stable stage of the illness, thereby increasing hope and quality of life.

The Molecular Immunology Centre of Havana, a Cuban state organisation, is the creator of all these vaccines.

In 1985 it developed the vaccine for meningitis B, the only one in the world, and later others that fight hepatitis B and dengue. For years, the centre has been conducting research to develop vaccines against AIDS-HIV.

The other Cuban state-run centre, Laboratories LABIOFAM, has developed homeopathic medicine for cancer such as VIDATOX, created from the blue scorpion’s venom. Cuba exports these medicines to 26 countries, and takes part in joint companies with China, Canada, and Spain.

All of this goes against the well-enforced stereotype, reinforced by the media silence regarding advances achieved by Cuba and other global south (so-called Third World) countries, that vanguard medical research takes place only in so-called developed countries.

Read More . . .

Translated by Tamara Pearson